The Human Endocannabinoid System (ECS) is an essential biological system present in all mammals, involved in regulating a broad spectrum of physiological processes, including memory, sleep, immune function, and more.

This system mainly comprises two kinds of cannabinoid receptors, CB1 and CB2. These receptors are specifically designed to interact with endocannabinoids, the cannabinoids produced naturally within the body. They can also engage with cannabinoids derived from plants, triggering a range of responses in different areas of the body.

Cannabinoids have shown potential for numerous therapeutic benefits, such as acting as antioxidants, neuroprotectors, anti-inflammatories, pain relievers, anti-tumor agents, sleep modulators, anti-psychotics, and anti-anxiety agents.

The most famous cannabinoid, delta-9-tetrahydrocannabinol (THC), is responsible for the psychoactive “high” that can alter perception, mood, emotions, cognitive abilities, and motor functions. Additionally, there are several cannabinoids like cannabidiol (CBD) that do not cause psychoactive effects but still possess valuable therapeutic properties.